Pharming Group N.V. - ADS, each representing 10 — Cash Flow (NASDAQ:PHAR) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities —37.84 M22.46 M17.3 M1.79 M54.71 M — Cash from investing activities —21.3 M5.32 M129.39 M31.62 M26.25 M — Cash from financing activities —27.95 M4.98 M1.04 M34.41 M1.5 M — Free cash flow —37.84 M22.46 M17.3 M1.79 M54.71 M —

News

Pharming Group N.V. (PHAR) Presents at 25th Annual Needham Virtual Healthcare Conference - Slideshow (NASDAQ:PHAR) 2026-04-13

Wainwright reiterates Pharming stock Buy rating on commercial growth

Pharming Q4 2025 slides: profitability inflection drives 27% growth

Pharming Group reports Q4 revenue of $106.5m, reaffirms 2026 guidance

Pharming earnings on deck as pipeline investment ramps up

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

US equity fund inflows ease as tech selloff weighs

Pharming Group: Crossing From Speculation To Profitability (NASDAQ:PHAR)

Pharming Group N.V. (PHAR) Analyst/Investor Day Transcript

Pharming shares surge as 2026 guidance tops analyst expectations

Why Pharming, A Top 3% Biotech Stock, Just Took A Double-Digit Beating

Pharming Group stock tumbles after FDA issues Complete Response Letter